title: Dynamic blood pressure load and nephropathy in the ZSF1 (fa/fa cp) model of type 2 diabetes.
abstract: Diabetes and increased blood pressure (BP) are believed to interact synergistically in the pathogenesis and progression of diabetic nephropathy. The present studies were performed to examine if there were differences in BP load and/or protective renal autoregulatory capacity between the obese diabetic Zucker fatty /spontaneously hypertensive heart failure F1 hybrid (ZSF1) (fa/fa cp) rats and their lean controls. By approximately 26 wk of age, ZSF1 (n = 13) but not their lean controls (n = 16) had developed substantial proteinuria (180 +/- 19 vs. 16 +/- 1.4 mg/24 h) and glomerulosclerosis (19 +/- 2.4 vs. 0.6 +/- 0.2%; P < 0.001). However, average ambient systolic BP by radiotelemetry (12-26 wk of age) was modestly lower in ZSF1 than in lean controls (130 +/- 1.4 vs. 137 +/- 1.7 mmHg, P < 0.002), although the 24-h BP power spectra showed a mild increase at frequencies <0.1 Hz in the ZSF1. Autoregulatory capacity under anesthesia in response to step changes in perfusion pressure between 100 and 140 mmHg was similarly well preserved in both ZSF1 and lean controls at 16-18 wk of age [autoregulatory indexes (AI) <0.1]. Similarly, differences were not observed for dynamic autoregulation in conscious rats [transfer functions between BP (input) and renal blood flow (output) using chronic Transonic flow probes]. Collectively, these data indicate that the pathogenesis of nephropathy in the ZSF1 model of type 2 diabetic nephropathy is largely independent of differences in systemic BP and/or its potential renal transmission. However, these data do not exclude the possibility that the diabetic milieu may alter the glomerular capillaries in the ZSF1, such that there is an enhanced local susceptibility to injury with even normal glomerular pressures.
authors.affiliation: Department of Internal Medicine, Loyola University Medical Center, 2160 S. First Ave., Maywood, IL 60153, USA. kgriffi@lumc.edu
authors.forename: Karen A
authors.initials: KA
authors.lastname: Griffin
authors.forename: Mohammad
authors.initials: M
authors.lastname: Abu-Naser
authors.forename: Isam
authors.initials: I
authors.lastname: Abu-Amarah
authors.forename: Maria
authors.initials: M
authors.lastname: Picken
authors.forename: Geoffrey A
authors.initials: GA
authors.lastname: Williamson
authors.forename: Anil K
authors.initials: AK
authors.lastname: Bidani
mesh_terms: D000818:Animals; D001794:Blood Pressure; D002678:Chimera; D003920:Diabetes Mellitus / Q000235:genetics; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000503:physiopathology*; D004195:Disease Models, Animal; D005923:Glomerulosclerosis, Focal Segmental / Q000503:physiopathology; D006333:Heart Failure / Q000235:genetics; D006706:Homeostasis; D007668:Kidney / Q000503:physiopathology; D008297:Male; D011507:Proteinuria / Q000503:physiopathology; D051381:Rats; D011918:Rats, Inbred SHR / Q000235:genetics; D011924:Rats, Zucker / Q000235:genetics